Massachusetts Financial Services CO Exelixis, Inc. Transaction History

Massachusetts Financial Services CO

$321 Billion
Q1 2024

A detailed history of Massachusetts Financial Services CO transactions in Exelixis, Inc. stock. As of the latest transaction made, Massachusetts Financial Services CO holds 450,605 shares of EXEL stock, worth $9.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

450,605

Previous 272,166 65.56%

Holding current value

$9.95 Million

Previous $6.53 Million 63.76%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$20.17 - $23.93 $3.6 Million - $4.27 Million	178,439 Added 65.56%	450,605 $10.7 Million
Q4 2023 Feb 08, 2024	SELL	$19.25 - $24.13 $115,423 - $144,683	-5,996 Reduced 2.16%	272,166 $6.53 Million
Q3 2023 Nov 08, 2023	SELL	$19.04 - $22.74 $69,819 - $83,387	-3,667 Reduced 1.3%	278,162 $6.08 Million
Q2 2023 Aug 09, 2023	BUY	$18.17 - $20.48 $25,637 - $28,897	1,411 Added 0.5%	281,829 $5.39 Million
Q1 2023 May 10, 2023	SELL	$16.3 - $19.41 $1.26 Million - $1.5 Million	-77,378 Reduced 21.63%	280,418 $5.44 Million

Q4 2022 Feb 13, 2023	BUY	$14.96 - $17.39 $1.66 Million - $1.92 Million	110,657 Added 44.78%	357,796 $5.74 Million
Q3 2022 Nov 09, 2022	BUY	$15.68 - $22.27 $252,604 - $358,769	16,110 Added 6.97%	247,139 $3.88 Million
Q2 2022 Aug 09, 2022	BUY	$17.44 - $23.16 $2.76 Million - $3.66 Million	158,121 Added 216.88%	231,029 $4.81 Million
Q1 2022 May 11, 2022	SELL	$17.03 - $22.67 $757,920 - $1.01 Million	-44,505 Reduced 37.9%	72,908 $1.65 Million
Q4 2021 Feb 10, 2022	BUY	$15.84 - $21.88 $1.56 Million - $2.16 Million	98,709 Added 527.74%	117,413 $2.15 Million
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $37.7 Million - $48.9 Million	-2,311,705 Reduced 99.2%	18,704 $395,000
Q2 2021 Aug 13, 2021	SELL	$17.95 - $25.56 $7.9 Million - $11.3 Million	-440,342 Reduced 15.89%	2,330,409 $42.5 Million
Q1 2021 May 13, 2021	SELL	$20.53 - $25.22 $16.2 Million - $19.9 Million	-790,485 Reduced 22.2%	2,770,751 $62.6 Million
Q4 2020 Feb 12, 2021	BUY	$18.39 - $24.8 $3.05 Million - $4.11 Million	165,659 Added 4.88%	3,561,236 $71.5 Million
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $23.8 Million - $31.1 Million	1,152,951 Added 51.41%	3,395,577 $83 Million
Q2 2020 Aug 11, 2020	BUY	$16.46 - $27.42 $36.7 Million - $61.2 Million	2,232,424 Added 21882.22%	2,242,626 $53.2 Million
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $324,063 - $488,559	-22,411 Reduced 68.72%	10,202 $176,000
Q4 2019 Feb 13, 2020	SELL	$15.15 - $18.89 $53,388 - $66,568	-3,524 Reduced 9.75%	32,613 $575,000
Q3 2019 Nov 05, 2019	BUY	$17.68 - $22.65 $638,902 - $818,503	36,137 New	36,137 $639,000
Q2 2018 Jul 30, 2018	SELL	$18.56 - $22.45 $179,753 - $217,428	-9,685 Closed	0 $0
Q1 2018 May 04, 2018	BUY	$22.15 - $31.89 $214,522 - $308,854	9,685 New	9,685 $215,000

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

246M

Call Options Held

1.7M

Put Options Held

1.02M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $7.11B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.

Account

Massachusetts Financial Services CO Exelixis, Inc. Transaction History